-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies - Opening Remarks

Program: Scientific Workshops @ ASH
Wednesday, December 2, 2020: 7:00 AM-7:05 AM
Moderator:
Disclosures:
Ansell: AI Therapeutics: Research Funding; Takeda: Research Funding; Regeneron: Research Funding; Affimed: Research Funding; Trillium: Research Funding; ADC Therapeutics: Research Funding; Bristol Myers Squibb: Research Funding; Seattle Genetics: Research Funding.
See more of: Scientific Workshops @ ASH
<< Previous Session | Next Session >>